SCHEMBL6080910

SCHEMBL6080910

CCOC(=O)C(C)(C)Oc1c(C)cc(CC(=O)OCc2ccccc2)cc1C

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
MAPK1 P28482 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
PPARA Q07869 7/20 0.44
PPARG P37231 4/20 0.44
MMP8 P22894 1/20 0.41
ABCB11 O95342 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
HTR2A P28223 1/20 0.41
PMP22 Q01453 1/20 0.41
ENPP2 Q13822 1/20 0.41
PAM P19021 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PPARD Q03181 2/20 0.40
RECQL P46063 1/20 0.39
FBP1 P09467 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5793165 0.89 ALDH1A1 (0.55) ALDH1A1MAPK1L3MBTL1PPARAPPARG
SCHEMBL6081371 0.83 PPARA (0.61) ALDH1A1MAPK1L3MBTL1PPARAPPARG
SCHEMBL6080934 0.83 ALDH1A1 (0.57) ALDH1A1MAPK1L3MBTL1PPARAPPARG
SCHEMBL5479990 0.81 PPID (0.37) ALDH1A1PPARAPPARGMMP8ABCB11
SCHEMBL6080648 0.80 CYP1A2 (0.47) ALDH1A1MAPK1L3MBTL1PPARAPPARG
SCHEMBL6080937 0.80 ALDH1A1 (0.49) ALDH1A1MAPK1L3MBTL1PPARAPPARG
SCHEMBL5484442 0.79 PPARA (0.41) ALDH1A1L3MBTL1PPARAPPARGMMP8
SCHEMBL5484449 0.79 PPARA (0.41) ALDH1A1L3MBTL1PPARAPPARGMMP8
SCHEMBL5479996 0.78 PPARA (0.39) PPARAPPARGMMP8ABCB11CYP1A2
SCHEMBL5477026 0.78 MMP8 (0.40) L3MBTL1PPARAPPARGMMP8SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060079696-A1 Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses GENFIT (FR) 2006-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079696-A1 Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses AADAC, NAT1, PARN ALDH1A1 845/4885MAPK1 3624/4885L3MBTL1 2320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.